DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.

BACKGROUND: Alzheimer's disease (AD) is the commonest cause of dementia. Cholinesterase inhibitors, such as donepezil, are the drug class with the best evidence of efficacy, licensed for mild to moderate AD, while the glutamate antagonist memantine has been widely prescribed, often in the later...

全面介绍

书目详细资料
Main Authors: Jones, R, Sheehan, B, Phillips, P, Juszczak, E, Adams, J, Baldwin, A, Ballard, C, Banerjee, S, Barber, B, Bentham, P, Brown, R, Burns, A, Dening, T, Findlay, D, Gray, R, Griffin, M, Holmes, C, Hughes, A, Jacoby, R, Johnson, T, Knapp, M, Lindesay, J, McKeith, I, McShane, R, Macharouthu, A, O'Brien, J, Onions, C, Passmore, P, Raftery, J, Ritchie, C, Howard, R
格式: Journal article
语言:English
出版: BioMed Central 2009

相似书籍